# Prognostic Value of miR-21 and miR-486 in Pulmonary Nodule Surgery

> **NCT07060287** · — · COMPLETED · sponsor: **The First Hospital of Hebei Medical University** · enrollment: 138 (actual)

## Conditions studied

- Pulmonary Nodule Cm

## Interventions

- **PROCEDURE:** Clock-Guided Minimally Invasive Surgery

## Key facts

- **NCT ID:** NCT07060287
- **Lead sponsor:** The First Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060287, "Prognostic Value of miR-21 and miR-486 in Pulmonary Nodule Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07060287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*